Interestingly, clinical benefit with T-DXd was observed in approximately one-third ... et al "Real-world clinical outcomes with sacituzumab govitecan in metastatic triple-negative breast cancer ...

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of cytotoxic T lymphocytes ...

A world-first clinical trial is hoping a successful brain cancer drug can help people fighting one of the deadliest forms of breast cancer.

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

UNUSUAL lumps or swelling anywhere on the body can be a sign of cancer. A lump in the breast is a typical sign of breast cancer everyone is taught to look for. Which is why when Steph Peacey ...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients ...

Based on these encouraging Emi-Le data at intermediate doses, Mersana has advanced a dose of 67.4 mg/m2 every four weeks into an expansion cohort in patients with TNBC who have received one to ...

To date, toripalimab has been approved for marketing in over 35 countries and regions around the world. In 2024 ... for the first-line treatment of recurrent or metastatic triple-negative breast ...

Surgical Prep and Recovery Nurse Christina Ferrarini, BSN, RN, CAPA, has spent her career caring for patients as they ...

Triple Negative Breast Cancer Treatment Market TNBC Companies are G1 Therapeutics ... the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure ...

The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a ...